Market Overview

VBI Vaccines (Nasdaq: VBIV)

1.28 -0.01 (-0.78%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2020
Pre-Market
EPS:
REV:
-0.15
647K



Q2 2020
Pre-Market
EPS:
REV:
-0.13
640K



Q1 2020
Pre-Market
EPS:
REV:
-0.15
360K



Q4 2019
Pre-Market
EPS:
REV:
-0.28
2.684M



Q3 2019
Pre-Market
EPS:
REV:
-0.24
259K

-0.15
647K

Q2 2019
Pre-Market
EPS:
REV:
-0.26
234K
-0.22
200K
-0.13
640K
40.91%
220%
Q1 2019
Pre-Market
EPS:
REV:
-0.19
178K
-0.22
200K
-0.15
360K
31.82%
80%
Q4 2018
Pre-Market
EPS:
REV:

-0.22
-0.28
2.684M
27.27%
Q3 2018
Pre-Market
EPS:
REV:

-0.22
200K
-0.24
259K
9.09%
29.5%
Q2 2018
Pre-Market
EPS:
REV:
-0.22
344K
-0.16
-0.26
234K
62.5%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!